NovaBay to Receive $5.7M Equity Investment from China Pioneer Pharma

NovaBay Pharmaceuticals (NYSE: NBY ) today announced that it has expanded its NeutroPhase® commercial partnership agreement with China Pioneer Pharma Holdings Limited. (HK: 1345) ("Pioneer"), a Shanghai-based company that markets high-end pharmaceutical products. This agreement replaces the previous option to invest $3 million in NovaBay. The expanded agreement